News

Disagreement on allowing products from the offspring of cloned animals onto the market in Europe has left plans to update all regulations on novel foods in tatters

With a strong pipeline of drugs in development, a good flow of venture capital investment and seven IPOs, 2010 was an “exceptional” year, says France Biotech

Europe continues to lead the way, attracting $94.4 B in 2010 - with Germany alone bringing in $41.2 B. But as global investment in clean energy reached a record $243 B, investment in the UK fell by 70%